Whitepaper | 12/1/2022

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Yajie Li, Vice President Technical, Parexel Regulatory and Access Consulting; Gary Cheng, Vice President, Health Advances; Eric Woo, Senior Analyst, Health Advances; Chao Wang, Scientific Data Strategy Leader, Parexel
As China has become the world’s second-largest economy and the largest developing country, its economy and market have assumed a prominent position in the Asia-Pacific region. The pharmaceutical industry is an important part of China’s national economy, with continuous strong demand, need, and capability for innovation. The industry continues to experience high levels of growth. With China’s increasing emphasis on the pharmaceutical industry, and the gradual improvement of healthcare policies, momentum supporting the development of China’s pharmaceutical market continues to accelerate.
Read here.

Share this: